Answer
Kivexa is contraindicated in people with hypersensitivity (allergy) to its active substances, abacavir or lamivudine, or to any excipient listed in section 6.1.
Sources for this answer
- Kivexa 600 mg/300 mg film-coated tabletsViiV Healthcare UK Ltd · emc · SmPC §4.3 Contraindications · Version 43Document updated
Sources checked